Blood tests to measure patients’ levels of antibodies can help predict their ability to fight infections and respond to treatment.
Around 10-20% of CLL patients develop antibodies which destroy their own red blood cells causing a condition called autoimmune haemolytic anaemia. A Direct Coombs test can reveal the presence of autoimmune haemolytic anaemia.
